“DNA Repair Defects in Metastatic Castrate Resistant Prostate Cancer” and “Making the Most in Graft-vs-Host: Biomarkers & Novel Treatment Strategies for GVHD” |
08/21/2017 - 12:00pm to 1:00pm |
“Direct Oral Anticoagulants for the Treatment of Cancer-Associated VTE” |
03/19/2018 - 12:00pm to 1:00pm |
“Development of the Glucocorticoid Receptor As A Novel Therapeutic Target in Prostate Cancer” |
08/28/2017 - 12:00pm to 1:00pm |
“Defining the Immune Landscape of Diffuse Large B-cell Lymphoma” |
01/22/2018 - 12:00pm to 1:00pm |
“Combining Antiangiogenic Agents and Immunotherapy: A New Strategy for Success in Renal Cell Carcinoma” |
07/02/2018 - 12:00pm to 1:00pm |
“Circulating Tumor DNA: An Overview of the Liquid Biopsy and Its Application in Lymphoid Malignancies” and “Combined Immune Checkpoint Blockade: Strategies in Melanoma to Manage Toxicity and Maintain Response” |
03/05/2018 - 12:00pm to 1:00pm |
“Chronic Lymphocytic Leukemia The Role of Ibrutinib in the First-Line Setting” and “Promise and Perils of Precision Medicine in Diffuse Large B-Cell Lymphoma” |
09/18/2017 - 12:00pm to 1:00pm |
“Cancer Risk Clinic & Center for Clinical Cancer Genetics Program Update |
10/23/2017 - 12:00pm to 1:00pm |
“BRAF Mutation in Colorectal Cancer” and “Targeting DNA Repair Pathways in Mesothelioma” |
11/27/2017 - 12:00pm to 1:00pm |
Trials and Tribulations: Immunotherapy, the Cost, and Patient Goals |
07/24/2017 - 12:00pm to 1:00pm |